What is pathophysiology of Lung cancer?

['Rogoca na tabana qo']

Na cava na pathophysiology ni kenisa ni yatevuso?

Na pathophysiology ni kenisa ni yatevuso e vakaibalebaletaki ena veisau ni ivakarau ni bula kei na ka e dau yaco ena gauna e tubu tiko kina na kenisa ni yatevuso.

Na kenisa ni yatevuso e mate vereverea e vu mai na tubu kei na kena tawasei na sela ni yatevuso.

Na sela oqo e rawa ni tubu me kenisa, qai tete ina so tale na tikiniyago, e vakavuna me levu na mate kei na leqa.

Na pathophysiology ni kenisa ni yatevuso e okati kina e vica na ka, okati kina na genetic mutations, environmental factors, kei na ivakarau ni bula.

E rawa ni yaco na veisau ni gene ena DNA ni sela ni yatevuso, e vakavuna me tubu qai tawase na sela.

Na veisau oqo e rawa ni dewa mai na dua na itubutubu se na kena e dewavi koya ga, qai rawa ni vu mai na kena ceguvi na tavako, na kasi gaga na radon, na kasi na asbestos, kei na cagi gaga.

Na kenisa ni yatevuso e rawa ni wasei ina rua na mataqali: na kenisa ni yatevuso e vakatokai na small cell lung cancer (SCLC) kei na kenisa ni yatevuso e vakatokai na non-small cell lung cancer (NSCLC).

E rawa ni duidui na mataqali kenisa ni yatevuso oqo, ni duidui na kena gene e dewa, qai duidui tale ga na kena isau.

Na pathophysiology ni kenisa ni yatevuso e okati tale ga kina na nodrau cakacaka vata na sela ni kenisa kei na tikiniyago e wavoliti rau, wili kina na sotia ni yago.

E rawa ni levea na sotia ni yago na sela ni kenisa, me tubu qai tete.

Kena ikuri, na microenvironment ni tumour e rawa ni vakavuna na tubu ni tumour kei na metastasis ena kena vakarautaki e dua na vanua vinaka me bula kina na sela ni kenisa.

Na pathophysiology ni kenisa ni yatevuso e vereverea qai toso tiko ga, ra qai saga tiko ga na dauvakadidike mera kila vinaka na ka e vakavuna me rawa ni yaga kina na veiqaravi e caka kei na kena vinaka na kedra ituvaki na tauvimate.

['iVakamacala']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Li Z, Qian Y, Li W, Liu L, Yu L, Liu X, Wu G, Wang Y, Luo W, Fang F, Liu Y, Song F, Cai Z, Chen W, Huang W: Human Lung Adenocarcinoma-Derived Organoid Models for Drug Screening. iScience. 2020, 23 (8): 101411.

Nurwidya F, Syahruddin E, Yunus F: Pain management in lung cancer. Adv Respir Med. 2016, 84 (6): 331-336.

Khan KA, Kennedy MP, Moore E, Crush L, Prendeville S, Maher MM, Burke L, Henry MT: Radiological characteristics, histological features and clinical outcomes of lung cancer patients with coexistent idiopathic pulmonary fibrosis. Lung. 2015, 193 (1): 71-7.

Paramanantham A, Asfiya R, Das S, McCully G, Srivastava A: Extracellular Vesicle (EVs) Associated Non-Coding RNAs in Lung Cancer and Therapeutics. Int J Mol Sci. 2022, 23 (21): .

Lee D, Kim Y, Chung C: Scientific Validation and Clinical Application of Lung Cancer Organoids. Cells. 2021, 10 (11): .

Mucchietto V, Crespi A, Fasoli F, Clementi F, Gotti C: Neuronal Acetylcholine Nicotinic Receptors as New Targets for Lung Cancer Treatment. Curr Pharm Des. 2016, 22 (14): 2160-9.

['iVakamacala: veiqaravi vakavuniwai']

['Na website qo e vakarautaki me baleta ga na vuli kei na itukutuku, e sega ni kena inaki me soli kina na ivakasala vakavuniwai se veiqaravi vakavuniwai.']

['Na itukutuku e vakarautaki e sega ni dodonu me vakayagataki me dikevi kina se me qaravi kina e dua na mate, o ira tale ga na via qara ivakasala vakavuniwai mera lai raici vuniwai.']

['Me nanumi tiko ni neural network e dau vakarautaka na isaunitaro e sega ni dau donu ena gauna e cakacakataki kina na iwiliwili, me vaka na kedra iwiliwili na tauvimate.']

['Ke o nanuma ni o tauvimate bibi, qirita na 911 se gole ina vanua ni veiqaravi e voleka vei iko. E sega ni dua na veiwekani e tauyavutaki ena website qo se na kena vakayagataki. E sega ni dua na ka e tukuna se cakava na BioMedLib se o ira na kena tamata cakacaka, se o ira na vakaitavi ena website qo me baleta na itukutuku e tiko kina se na kena vakayagataki.']

['Disclaimer: dodonu ni lavelavetaki']

['Na Digital Millennium Copyright Act ni 1998, 17 U.S.C. § 512 (na DMCA) e vakarautaka na recourse me baleta na itaukei ni dodonu ni lavelavetaki era vakabauta ni iyaya e basika ena Initaneti e voroka na nodra dodonu ena ruku ni lawa ni dodonu ni lavelavetaki ni Amerika. ']

['Ke o vakabauta ni dua na ka e tabaki ena neimami website se na neimami veiqaravi e beci kina na nomu dodonu ni kena maroroi na itukutuku, o iko (se nomu mata) e rawa ni o vakauta mai e dua na notisi mo kerea me kau laivi se me tarovi na kena vakayagataki. ']

['Me vakau na itukutuku ena i-meli (raica na "Veitaratara" ena tabana e baleta na itikotiko ni imeli). ']

['Na DMCA e gadrevi kina na nomu itukutuku ni kena beitaki ni beci na dodonu ni lavelavetaki e oka kina na itukutuku oqo: (1) ivakamacala ni cakacaka ni taqomaki ni dodonu ni lavelavetaki e tukuni ni sa beci; (2) ivakamacala ni lewena e beitaki ni beci kei na itukutuku e veirauti me rawa kina ni da kunea na lewena; (3) itukutuku ni veitaratara me baleti iko, oka kina na nomu itikotiko, naba ni talevoni kei na itikotiko ni imeli; (4) e dua na itukutuku mai vei iko ni o vakabauta ena vakabauta vinaka ni lewena ena kena ivakarau e kudruvaka e sega ni vakadonui mai vua na itaukei ni dodonu ni lavelavetaki, se na kena mata, se ena cakacaka ni dua na lawa; ']

['(5) e dua na nomu ivakamacala, e sainitaki ena itotogi ni bubului lasu, ni dina na itukutuku e volai ena notisi, ni tu tale ga vei iko na dodonu mo valataka na dodonu ni kena taqomaki na ka e volai; ']

['E sega ni dodonu me dua na ka e caka ena kena vakayagataki na Internet.']

['Ke o sega ni vola na itukutuku kece qori, ena rawa ni berabera na kena qaravi na nomu kudru.']

['Veitaratara']

['Yalovinaka vakauta mai na imeli ena dua na taro se vakatutu.']

What is pathophysiology of lung cancer?

The pathophysiology of lung cancer refers to the changes in the normal physiological processes and mechanisms that occur in the development and progression of lung cancer.

Lung cancer is a complex disease that arises from the uncontrolled growth and division of abnormal cells in the lungs.

These cells can form tumors and spread to other parts of the body, leading to various symptoms and complications.

The pathophysiology of lung cancer involves several factors, including genetic mutations, environmental factors, and lifestyle choices.

Genetic mutations can occur in the DNA of lung cells, leading to uncontrolled cell growth and division.

These mutations can be inherited or acquired, and they can be caused by exposure to carcinogens, such as tobacco smoke, radon, asbestos, and air pollution.

Lung cancer can be classified into two main types: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). NSCLC is further divided into three subtypes: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.

The pathophysiology of these types of lung cancer can differ, as they have different genetic mutations and respond differently to treatment.

The pathophysiology of lung cancer also involves the interaction between cancer cells and the surrounding tissue, including the immune system.

Cancer cells can evade the immune system, allowing them to grow and spread unchecked.

Additionally, the tumor microenvironment can promote tumor growth and metastasis by providing a supportive environment for cancer cells.

The pathophysiology of lung cancer is a complex and dynamic process, and researchers are continuously working to better understand the underlying mechanisms to develop more effective treatments and improve patient outcomes.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.